Nathan Weinstein

Nathan Weinstein

Director – Healthcare Analyst
Mr. Weinstein, CFA, began his career as an analyst intern at NGN Capital, a life sciences focused venture capital firm. Mr. Weinstein went on to work at Sidoti & Company and CL King & Associates. At those firms, Mr. Weinstein was involved with institutional equities, actively facilitating the distribution of equity research to investors including pension, mutual, and hedge-funds. Mr. Weinstein provided his clients with long/short idea flow, proprietary surveys, corporate access and conferences and led a successful business development effort that on boarded a significant number of new clients. Mr. Weinstein graduated from Binghamton University with degrees in Economics and English.

Companies Covered (By Industry)

Diagnostics

BMRA Biomerica, Inc.
VNRX VolitionRX Ltd.

Biotechnology

ANIX Anixa Biosciences, Inc.
AMRN Amarin Corporation plc.
ACST Acasti Pharma Inc.
DARE Dare Bioscience, Inc.
KTRA Kintara Therapeutics, Inc.
MBII Marrone Bio Innovations
MTNB Matinas BioPharma Holdings, Inc
ORMP Oramed Pharmaceuticals, Inc.
SCYX SCYNEXIS

Animal Health

ICCC ImmuCell
KIN Kindred Biosciences

Medical Devices and MedTech

AVGR Avinger, Inc.
CSII Cardiovascular Systems, Inc.
DRIO DarioHealth Corp.
DYNT Dynatronics
EKSO Ekso Bionics